BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19724220)

  • 1. Herpes simplex virus keratitis: histopathologic neovascularization and corneal allograft failure.
    Garcia DD; Shtein RM; Musch DC; Elner VM
    Cornea; 2009 Oct; 28(9):963-5. PubMed ID: 19724220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSV keratitis: histopathologic predictors of corneal allograft complications.
    Shtein RM; Garcia DD; Musch DC; Elner VM
    Trans Am Ophthalmol Soc; 2008; 106():161-68; discussion 168-70. PubMed ID: 19277231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus keratitis: histopathologic inflammation and corneal allograft rejection.
    Shtein RM; Garcia DD; Musch DC; Elner VM
    Ophthalmology; 2009 Jul; 116(7):1301-5. PubMed ID: 19576497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis.
    Moyes AL; Sugar A; Musch DC; Barnes RD
    Arch Ophthalmol; 1994 May; 112(5):601-7. PubMed ID: 8185515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Highly active antiviral and immunosuppressive combination therapy with acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease].
    Reisr A; Reinhard T; Voiculescu A; Mayer K; Sundmacher R
    Klin Monbl Augenheilkd; 2001 Mar; 218(3):183-6. PubMed ID: 11322055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis.
    Lomholt JA; Baggesen K; Ehlers N
    Acta Ophthalmol Scand; 1995 Feb; 73(1):29-32. PubMed ID: 7627755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis.
    Foster CS; Barney NP
    Doc Ophthalmol; 1992; 80(4):363-9. PubMed ID: 1473452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.
    Garcia DD; Farjo Q; Musch DC; Sugar A
    Cornea; 2007 Sep; 26(8):930-4. PubMed ID: 17721290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcome of penetrating keratoplasty for corneal scarring due to herpes simplex keratitis.
    Altay Y; Tamer S; Kaya AS; Balta O; Burcu A; Ornek F
    Arq Bras Oftalmol; 2017; 80(1):41-45. PubMed ID: 28380101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral herpetic keratoconjunctivitis.
    Souza PM; Holland EJ; Huang AJ
    Ophthalmology; 2003 Mar; 110(3):493-6. PubMed ID: 12623810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization.
    Yoon KC; Im SK; Park HY
    Cornea; 2010 Apr; 29(4):465-7. PubMed ID: 20164757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis.
    Maier AK; Ozlügedik S; Rottler J; Heussen FM; Klamann MK; Huber KK; Joussen AM; Winterhalter S
    Cornea; 2011 Dec; 30(12):1398-405. PubMed ID: 21996945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent herpetic keratitis in penetrating keratoplasty.
    Sterk CC; Jager MJ; Swart-vd Berg M
    Doc Ophthalmol; 1995; 90(1):29-33. PubMed ID: 8549240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.
    Wu SQ; Zhou P; Zhang B; Qiu WY; Yao YF
    Am J Ophthalmol; 2012 Feb; 153(2):291-299.e2. PubMed ID: 21996306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.
    Tambasco FP; Cohen EJ; Nguyen LH; Rapuano CJ; Laibson PR
    Arch Ophthalmol; 1999 Apr; 117(4):445-9. PubMed ID: 10206570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease.
    Altenburger AE; Bachmann B; Seitz B; Cursiefen C
    Graefes Arch Clin Exp Ophthalmol; 2012 Nov; 250(11):1663-71. PubMed ID: 22419035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis.
    Akova YA; Onat M; Duman S
    Ocul Immunol Inflamm; 1999 Mar; 7(1):51-60. PubMed ID: 10410875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postoperative therapy after penetrating keratoplasty in herpes simplex keratitis].
    Süveges I; Füst Á; Imre L
    Orv Hetil; 2013 Dec; 154(52):2065-70. PubMed ID: 24374582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.
    Barney NP; Foster CS
    Cornea; 1994 May; 13(3):232-6. PubMed ID: 8033573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term visual outcomes, graft survival and complications of deep anterior lamellar keratoplasty in patients with herpes simplex related corneal scarring.
    Lyall DA; Tarafdar S; Gilhooly MJ; Roberts F; Ramaesh K
    Br J Ophthalmol; 2012 Sep; 96(9):1200-3. PubMed ID: 22826552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.